TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Eql Pharma AB
Closing information (x1000 EUR)
Closing information | 2022/03 (consolidated) | 2021/03 (consolidated) | 2020/03 (consolidated) |
Turnover | 39,634 | 17,498 | 6,499 |
Financial expenses | 278 | 98 | 39 |
Earnings before taxes | 3,479 | 1,020 | 246 |
EBITDA | 4,354 | 2,805 | 658 |
Total assets | 23,010 | 19,421 | 11,216 |
Current assets | 11,941 | 9,566 | 5,532 |
Current liabilities | 9,552 | 9,273 | 3,915 |
Equity capital | 11,958 | 8,918 | 7,301 |
- share capital | 127 | 128 | 118 |
Employees (average) | 13 | 10 | 8 |
Financial ratios
Fiscal year | 2022/03 (consolidated) | 2021/03 (consolidated) | 2020/03 (consolidated) |
Solvency | 52.0% | 45.9% | 65.1% |
Turnover per employee | 3,049 | 1,750 | 812 |
Profit as a percentage of turnover | 8.8% | 5.8% | 3.8% |
Return on assets (ROA) | 16.3% | 5.8% | 2.5% |
Current ratio | 125.0% | 103.2% | 141.3% |
Return on equity (ROE) | 29.1% | 11.4% | 3.4% |
Change turnover | 22,306 | 10,463 | 2,010 |
Change turnover % | 129% | 149% | 45% |
Chg. No. of employees | 3 | 2 | 1 |
Chg. No. of employees % | 30% | 25% | 14% |
Total value of public sale
Fiscal year | 2022/03 (consolidated) | 2021/03 (consolidated) | 2020/03 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.